Company / Current Assets per Share
Roivant Sciences Current Assets per Share History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$8.35
FY2024
5-year range
$2.37 / $8.35
FY2021-FY2024
Trend
+252.7%
vs FY2023
Sector context
#89 of 210
Health Care
What the data says
Current Assets per Share changed +253% YoY in FY2024, a notable deviation from the 3-year average annual change of +75%.
Based on SEC 10-K filings.
8.35 in FY2024 with a 3-year CAGR of +36.7%.
Improved from $3.29 to $8.35 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +36.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#89 of 210 in Health CareTop 42% of 210This company $8.35 Sector average $134.38
▼
-93.8% below sector average
Key checks
Key Insights
- In FY2024, current assets per share increased 252.7% year-over-year.
- Ranks #89 out of 210 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $8.35 | +252.7% |
| FY2023 | $2.37 | -28.2% |
| FY2022 | $3.29 | +0.9% |
| FY2021 | $3.27 | - |
| FY2020 | - | - |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026